首页 > 最新文献

Toxicologic Pathology最新文献

英文 中文
International Harmonization of Nomenclature and Diagnostic Criteria (INHAND): Nonproliferative and Proliferative Lesions of Nonrodent Ocular Tissues. 国际协调命名和诊断标准(INHAND):非啮齿动物眼部组织的非增殖性和增殖性病变。
IF 1.4 4区 医学 Q3 PATHOLOGY Pub Date : 2024-10-01 DOI: 10.1177/01926233241283708
K A Schafer, E Atzpodien, U Bach, J Bartoe, H Booler, J Brassard, C Farman, M Kochi, T Lejeune, E Meseck, T Nolte, M Ramos, B Short, S Sorden, L Teixeira, O Turner, B Walling, K Yekkala, K Yoshizawa

The INHAND (International Harmonization of Nomenclature and Diagnostic Criteria for Lesions) Project (www.toxpath.org/ inhand.asp) is a joint initiative of the Societies of Toxicologic Pathology from Europe (ESTP), Great Britain (BSTP), Japan (JSTP), and North America (STP) to develop an internationally accepted nomenclature for proliferative and nonproliferative lesions in laboratory animals. The purpose of this publication is to provide a standardized nomenclature for classifying lesions observed in ocular tissues (eyes and glands and ocular adnexa) from laboratory nonrodent species (rabbits, dogs, minipigs, and nonhuman primates) used in nonclinical safety studies with an emphasis on ocular-targeted dosing. Some of the lesions are illustrated by color photomicrographs. The standardized nomenclature presented in this document is also available electronically on the Internet (http://www.goreni.org/). Sources of material included histopathology databases from government, academia, and industrial laboratories throughout the world. Content includes descriptions and visual depictions of spontaneous lesions and lesions induced by exposure to various test materials. A widely accepted and utilized internationally harmonized nomenclature for lesions in laboratory animals will provide a common language among regulatory and scientific research organizations in different countries and increase and enrich international exchanges of information among toxicologists and pathologists.

INHAND(国际病变命名和诊断标准统一)项目(www.toxpath.org/ INHAND .asp)是欧洲(ESTP)、英国(BSTP)、日本(JSTP)和北美(STP)的毒理学病理学会的联合倡议,旨在为实验动物的增殖性和非增殖性病变制定国际公认的命名法。本出版物的目的是为用于非临床安全性研究的非啮齿动物(兔子、狗、迷你猪和非人灵长类动物)的眼部组织(眼睛、腺体和眼附件)中观察到的病变提供一个标准化的命名法,重点是眼部靶向给药。彩色显微照片显示了一些病变。本文档中提出的标准化命名法也可在互联网上以电子方式获得(http://www.goreni.org/)。材料来源包括来自世界各地政府、学术界和工业实验室的组织病理学数据库。内容包括自发性病变和暴露于各种测试材料引起的病变的描述和视觉描述。一个被广泛接受和使用的国际上统一的实验动物损伤命名法将为不同国家的监管和科学研究组织提供一种共同的语言,并增加和丰富毒理学家和病理学家之间的国际信息交流。
{"title":"International Harmonization of Nomenclature and Diagnostic Criteria (INHAND): Nonproliferative and Proliferative Lesions of Nonrodent Ocular Tissues.","authors":"K A Schafer, E Atzpodien, U Bach, J Bartoe, H Booler, J Brassard, C Farman, M Kochi, T Lejeune, E Meseck, T Nolte, M Ramos, B Short, S Sorden, L Teixeira, O Turner, B Walling, K Yekkala, K Yoshizawa","doi":"10.1177/01926233241283708","DOIUrl":"10.1177/01926233241283708","url":null,"abstract":"<p><p>The INHAND (International Harmonization of Nomenclature and Diagnostic Criteria for Lesions) Project (www.toxpath.org/ inhand.asp) is a joint initiative of the Societies of Toxicologic Pathology from Europe (ESTP), Great Britain (BSTP), Japan (JSTP), and North America (STP) to develop an internationally accepted nomenclature for proliferative and nonproliferative lesions in laboratory animals. The purpose of this publication is to provide a standardized nomenclature for classifying lesions observed in ocular tissues (eyes and glands and ocular adnexa) from laboratory nonrodent species (rabbits, dogs, minipigs, and nonhuman primates) used in nonclinical safety studies with an emphasis on ocular-targeted dosing. Some of the lesions are illustrated by color photomicrographs. The standardized nomenclature presented in this document is also available electronically on the Internet (http://www.goreni.org/). Sources of material included histopathology databases from government, academia, and industrial laboratories throughout the world. Content includes descriptions and visual depictions of spontaneous lesions and lesions induced by exposure to various test materials. A widely accepted and utilized internationally harmonized nomenclature for lesions in laboratory animals will provide a common language among regulatory and scientific research organizations in different countries and increase and enrich international exchanges of information among toxicologists and pathologists.</p>","PeriodicalId":23113,"journal":{"name":"Toxicologic Pathology","volume":"52 7","pages":"368-455"},"PeriodicalIF":1.4,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142807221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exogenous Growth Hormone Exacerbates Post-Irradiation Atherosclerosis in Susceptible Epicardial Coronary Arteries 外源性生长激素加剧易受辐射影响的心外膜冠状动脉辐射后动脉粥样硬化
IF 1.5 4区 医学 Q3 PATHOLOGY Pub Date : 2024-09-10 DOI: 10.1177/01926233241277454
Krystal J. Vail, J. Daniel Bourland, Gregory O. Dugan, Benny J. Chen, Thomas B. Clarkson, J. Mark Cline, Giselle C. Meléndez
Cardiac exposure to ionizing radiation can damage both the microvasculature and coronary arteries, as well as increase the long-term risk of heart disease, myocardial fibrosis, and conduction abnormalities. Therapeutic agents capable of promoting recovery from radiation injury to the heart are limited. Growth hormone is linked to improved cardiac function following injury. Here, we leveraged a cynomolgus macaque model to determine the long-term outcomes of recombinant human growth hormone (rhGH) therapy on the heart following low-dose ionizing radiation. Macaques were exposed to 2 Gy radiation, treated with rhGH for one month, and assessed after 2 years. Overall, plasma lipid profile, cardiac function, and coronary artery disease were similar between rhGH and placebo treated animals. However, a subgroup of rhGH-treated animals exhibited more extensive atherosclerotic plaques in the coronary arteries. Together, these findings indicate that transient human growth hormone therapy subsequent to a single low dose of ionizing radiation involving the heart does not result in long-term changes to plasma cholesterol but may promote exacerbated coronary artery disease in a subset of individuals.
心脏暴露于电离辐射会损伤微血管和冠状动脉,并增加患心脏病、心肌纤维化和传导异常的长期风险。能够促进心脏从辐射损伤中恢复的治疗药物非常有限。生长激素与损伤后心脏功能的改善有关。在这里,我们利用猕猴模型来确定重组人生长激素(rhGH)疗法对低剂量电离辐射后心脏的长期影响。猕猴受到2 Gy辐射,接受一个月的rhGH治疗,两年后进行评估。总体而言,接受rhGH和安慰剂治疗的动物的血浆脂质状况、心脏功能和冠状动脉疾病情况相似。然而,一部分接受过rhGH治疗的动物的冠状动脉出现了更广泛的动脉粥样硬化斑块。总之,这些研究结果表明,对心脏进行单次低剂量电离辐射后的短暂人体生长激素治疗不会导致血浆胆固醇的长期变化,但可能会促使一部分人的冠状动脉疾病恶化。
{"title":"Exogenous Growth Hormone Exacerbates Post-Irradiation Atherosclerosis in Susceptible Epicardial Coronary Arteries","authors":"Krystal J. Vail, J. Daniel Bourland, Gregory O. Dugan, Benny J. Chen, Thomas B. Clarkson, J. Mark Cline, Giselle C. Meléndez","doi":"10.1177/01926233241277454","DOIUrl":"https://doi.org/10.1177/01926233241277454","url":null,"abstract":"Cardiac exposure to ionizing radiation can damage both the microvasculature and coronary arteries, as well as increase the long-term risk of heart disease, myocardial fibrosis, and conduction abnormalities. Therapeutic agents capable of promoting recovery from radiation injury to the heart are limited. Growth hormone is linked to improved cardiac function following injury. Here, we leveraged a cynomolgus macaque model to determine the long-term outcomes of recombinant human growth hormone (rhGH) therapy on the heart following low-dose ionizing radiation. Macaques were exposed to 2 Gy radiation, treated with rhGH for one month, and assessed after 2 years. Overall, plasma lipid profile, cardiac function, and coronary artery disease were similar between rhGH and placebo treated animals. However, a subgroup of rhGH-treated animals exhibited more extensive atherosclerotic plaques in the coronary arteries. Together, these findings indicate that transient human growth hormone therapy subsequent to a single low dose of ionizing radiation involving the heart does not result in long-term changes to plasma cholesterol but may promote exacerbated coronary artery disease in a subset of individuals.","PeriodicalId":23113,"journal":{"name":"Toxicologic Pathology","volume":"64 1","pages":"1926233241277454"},"PeriodicalIF":1.5,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142177883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Toxicologic Pathology Forum*: mRNA Vaccine Safety–Separating Fact From Fiction 毒理病理学论坛*:mRNA 疫苗安全性--分清事实与虚构
IF 1.5 4区 医学 Q3 PATHOLOGY Pub Date : 2024-09-10 DOI: 10.1177/01926233241278298
Rani S. Sellers, Philip R. Dormitzer
SARS-CoV-2 spread rapidly across the globe, contributing to the death of millions of individuals from 2019 to 2023, and has continued to be a major cause of morbidity and mortality after the pandemic. At the start of the pandemic, no vaccines or anti-viral treatments were available to reduce the burden of disease associated with this virus, as it was a novel SARS coronavirus. Because of the tremendous need, the development of vaccines to protect against COVID-19 was critically important. The flexibility and ease of manufacture of nucleic acid–based vaccines, specifically mRNA-based products, allowed the accelerated development of COVID-19 vaccines. Although mRNA-based vaccines and therapeutics had been in clinical trials for over a decade, there were no licensed mRNA vaccines on the market at the start of the pandemic. The rapid development of mRNA-based COVID-19 vaccines reduced serious complications and death from the virus but also engendered significant public concerns, which continue now, years after emergency-use authorization and subsequent licensure of these vaccines. This article summarizes and addresses some of the safety concerns that continue to be expressed about these vaccines and their underlying technology.
从 2019 年到 2023 年,SARS-CoV-2 在全球迅速蔓延,导致数百万人死亡,在大流行之后,它仍然是发病和死亡的主要原因。大流行之初,由于该病毒是一种新型 SARS 冠状病毒,因此没有疫苗或抗病毒治疗方法来减轻与之相关的疾病负担。由于需求量巨大,开发可预防 COVID-19 的疫苗就显得至关重要。以核酸为基础的疫苗,特别是以 mRNA 为基础的产品的灵活性和易制造性使 COVID-19 疫苗的开发得以加速。尽管基于 mRNA 的疫苗和疗法已进行了十多年的临床试验,但在大流行开始时,市场上还没有获得许可的 mRNA 疫苗。基于 mRNA 的 COVID-19 疫苗的快速开发减少了病毒造成的严重并发症和死亡,但也引起了公众的极大关注,这种关注在这些疫苗获得紧急使用授权和随后的许可多年后的今天仍在继续。本文总结并讨论了人们对这些疫苗及其基础技术的安全性持续表达的一些担忧。
{"title":"Toxicologic Pathology Forum*: mRNA Vaccine Safety–Separating Fact From Fiction","authors":"Rani S. Sellers, Philip R. Dormitzer","doi":"10.1177/01926233241278298","DOIUrl":"https://doi.org/10.1177/01926233241278298","url":null,"abstract":"SARS-CoV-2 spread rapidly across the globe, contributing to the death of millions of individuals from 2019 to 2023, and has continued to be a major cause of morbidity and mortality after the pandemic. At the start of the pandemic, no vaccines or anti-viral treatments were available to reduce the burden of disease associated with this virus, as it was a novel SARS coronavirus. Because of the tremendous need, the development of vaccines to protect against COVID-19 was critically important. The flexibility and ease of manufacture of nucleic acid–based vaccines, specifically mRNA-based products, allowed the accelerated development of COVID-19 vaccines. Although mRNA-based vaccines and therapeutics had been in clinical trials for over a decade, there were no licensed mRNA vaccines on the market at the start of the pandemic. The rapid development of mRNA-based COVID-19 vaccines reduced serious complications and death from the virus but also engendered significant public concerns, which continue now, years after emergency-use authorization and subsequent licensure of these vaccines. This article summarizes and addresses some of the safety concerns that continue to be expressed about these vaccines and their underlying technology.","PeriodicalId":23113,"journal":{"name":"Toxicologic Pathology","volume":"4 1","pages":"1926233241278298"},"PeriodicalIF":1.5,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142177884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intra-abdominal Abscesses in Two Göttingen Minipigs. 两只哥廷根小型猪的腹内脓肿
IF 1.4 4区 医学 Q3 PATHOLOGY Pub Date : 2024-08-01 Epub Date: 2024-10-17 DOI: 10.1177/01926233241289112
Nanna Grand, Gitte Jeppesen, Abraham Nyska

Minipigs are valued alternatives to dogs and non-human primates in non-clinical safety and toxicity studies, and Göttingen minipigs are bred specifically for experimental purposes. They are bred under barrier conditions and monitored regularly for many pathogens and opportunistic agents, and spontaneous disease is rare when compared to what is seen in production pigs. Knowledge of spontaneous background lesions is important when toxicological pathologists evaluate microscopic findings in pre-clinical toxicity studies to avoid interference with study data interpretation. In this brief communication, intra-abdominal granulomas/abscesses were seen in Göttingen minipigs. The minipigs did not show any clinical signs, but nodules were present in the abdominal peritoneum at necropsy. Microscopic evaluation revealed chronic inflammation, with abscess or granuloma formation. Areas of inflammation, occasionally associated with the presence of the Splendore-Hoeppli material, were surrounded by a fibrotic capsule. Special stains were applied to investigate for the presence of microorganisms.

在非临床安全性和毒性研究中,迷你猪是狗和非人灵长类动物的重要替代品,哥廷根迷你猪是专门为实验目的而饲养的。小猪在隔离条件下饲养,并定期监测多种病原体和机会性病原体,与生产猪相比,小猪很少发生自发性疾病。当毒理学病理学家评估临床前毒性研究中的显微镜检查结果时,了解自发性背景病变非常重要,可避免干扰研究数据的解释。在本简讯中,哥廷根小型猪腹腔内肉芽肿/脓肿。小猪没有出现任何临床症状,但在尸体解剖时腹腔腹膜出现结节。显微镜评估显示存在慢性炎症,并有脓肿或肉芽肿形成。炎症区域偶尔会出现 Splendore-Hoeppli 物质,周围有纤维化包囊。采用特殊染色法检查是否存在微生物。
{"title":"Intra-abdominal Abscesses in Two Göttingen Minipigs.","authors":"Nanna Grand, Gitte Jeppesen, Abraham Nyska","doi":"10.1177/01926233241289112","DOIUrl":"10.1177/01926233241289112","url":null,"abstract":"<p><p>Minipigs are valued alternatives to dogs and non-human primates in non-clinical safety and toxicity studies, and Göttingen minipigs are bred specifically for experimental purposes. They are bred under barrier conditions and monitored regularly for many pathogens and opportunistic agents, and spontaneous disease is rare when compared to what is seen in production pigs. Knowledge of spontaneous background lesions is important when toxicological pathologists evaluate microscopic findings in pre-clinical toxicity studies to avoid interference with study data interpretation. In this brief communication, intra-abdominal granulomas/abscesses were seen in Göttingen minipigs. The minipigs did not show any clinical signs, but nodules were present in the abdominal peritoneum at necropsy. Microscopic evaluation revealed chronic inflammation, with abscess or granuloma formation. Areas of inflammation, occasionally associated with the presence of the Splendore-Hoeppli material, were surrounded by a fibrotic capsule. Special stains were applied to investigate for the presence of microorganisms.</p>","PeriodicalId":23113,"journal":{"name":"Toxicologic Pathology","volume":" ","pages":"350-352"},"PeriodicalIF":1.4,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142475474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Classic Lesions of the Biliary Tree. 胆管的典型病变
IF 1.4 4区 医学 Q3 PATHOLOGY Pub Date : 2024-08-01 Epub Date: 2024-08-27 DOI: 10.1177/01926233241257912
John M Cullen, David Malarkey, John R Foster

Abnormal findings in the biliary tree are frequently encountered in response to acute and chronic exposures to various compounds. The more common findings are described here in an overview of previous publications such as the INHAND Proliferative and Nonproliferative Lesions of the Rodent Liver and the Liver-Nonneoplastic Lesion Atlas NTP with comments regarding current considerations. This was presented at the 2023 Annual Meeting of the Society of Toxicologic Pathology. Histologic descriptions and some discussions regarding the pathogenesis of the various categories of non-neoplastic lesions in the biliary tree are presented. Discussions regarding the use of the term oval cell versus ductular reaction and the potentially neoplastic nature of cholangiofibrosis are presented in some detail.

急性和慢性接触各种化合物时,经常会在胆管中发现异常。本文概述了以前的出版物,如《INHAND 啮齿动物肝脏的增生性和非增生性病变》和《NTP 肝脏非肿瘤性病变图谱》,并对当前的考虑因素进行了评论,从而描述了更常见的发现。这是在毒理学病理学学会 2023 年年会上发表的论文。报告介绍了组织学描述以及有关胆道树各类非肿瘤性病变发病机制的一些讨论。还详细讨论了卵圆形细胞与导管反应这一术语的使用以及胆管纤维化的潜在肿瘤性质。
{"title":"Classic Lesions of the Biliary Tree.","authors":"John M Cullen, David Malarkey, John R Foster","doi":"10.1177/01926233241257912","DOIUrl":"10.1177/01926233241257912","url":null,"abstract":"<p><p>Abnormal findings in the biliary tree are frequently encountered in response to acute and chronic exposures to various compounds. The more common findings are described here in an overview of previous publications such as the INHAND Proliferative and Nonproliferative Lesions of the Rodent Liver and the Liver-Nonneoplastic Lesion Atlas NTP with comments regarding current considerations. This was presented at the 2023 Annual Meeting of the Society of Toxicologic Pathology. Histologic descriptions and some discussions regarding the pathogenesis of the various categories of non-neoplastic lesions in the biliary tree are presented. Discussions regarding the use of the term oval cell versus ductular reaction and the potentially neoplastic nature of cholangiofibrosis are presented in some detail.</p>","PeriodicalId":23113,"journal":{"name":"Toxicologic Pathology","volume":" ","pages":"353-362"},"PeriodicalIF":1.4,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142073932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Minimal Approach to Demonstrate Concordance of Digital and Conventional Microscopy in Toxicologic Pathology. 在毒理病理学中展示数字显微镜和传统显微镜一致性的最低限度方法。
IF 1.4 4区 医学 Q3 PATHOLOGY Pub Date : 2024-07-01 Epub Date: 2024-06-03 DOI: 10.1177/01926233241255125
Charlotte Lempp, Stefanie Arms, Christof Albert Bertram, Robert Klopfleisch, Bernd-Wolfgang Igl, Leonie Hezler, Thomas Nolte, Gabriele Pohlmeyer-Esch

Digitalization of pathology workflows has undergone a rapid evolution and has been widely established in the diagnostic field but remains a challenge in the nonclinical safety context due to lack of regulatory guidance and validation experience for good laboratory practice (GLP) use. One means to demonstrate that digital slides are fit for purpose, that is, provide sufficient quality for pathologists to reach a diagnosis, is conduction of comparison studies, which have been published both, for veterinary and human diagnostic pathology, but not for toxicologic pathology. Here, we present an approach that uses study material from nonclinical safety studies and that allows for the statistical comparison of concordance rates for glass and digital slide evaluation while minimizing time and effort for the involved personnel. Using a benchmark study design, we demonstrate that evaluation of digital slides fits the purpose of nonclinical safety evaluation. These results add to reports of successful workflow validations and support the full adaptation of digital pathology in the regulatory field.

病理工作流程的数字化经历了快速的发展,并在诊断领域得到了广泛应用,但由于缺乏良好实验室规范(GLP)使用的监管指导和验证经验,在非临床安全方面仍面临挑战。要证明数字切片适用于目的,即为病理学家提供足够的诊断质量,一种方法是进行对比研究,这种研究已在兽医和人类病理诊断领域发表,但尚未在毒理病理领域发表。在此,我们介绍一种使用非临床安全性研究材料的方法,该方法可对玻璃切片和数字切片评估的一致率进行统计比较,同时最大限度地减少相关人员的时间和精力。通过基准研究设计,我们证明了数字幻灯片评估符合非临床安全性评估的目的。这些结果是对成功的工作流程验证报告的补充,支持了数字病理学在监管领域的全面应用。
{"title":"A Minimal Approach to Demonstrate Concordance of Digital and Conventional Microscopy in Toxicologic Pathology.","authors":"Charlotte Lempp, Stefanie Arms, Christof Albert Bertram, Robert Klopfleisch, Bernd-Wolfgang Igl, Leonie Hezler, Thomas Nolte, Gabriele Pohlmeyer-Esch","doi":"10.1177/01926233241255125","DOIUrl":"10.1177/01926233241255125","url":null,"abstract":"<p><p>Digitalization of pathology workflows has undergone a rapid evolution and has been widely established in the diagnostic field but remains a challenge in the nonclinical safety context due to lack of regulatory guidance and validation experience for good laboratory practice (GLP) use. One means to demonstrate that digital slides are fit for purpose, that is, provide sufficient quality for pathologists to reach a diagnosis, is conduction of comparison studies, which have been published both, for veterinary and human diagnostic pathology, but not for toxicologic pathology. Here, we present an approach that uses study material from nonclinical safety studies and that allows for the statistical comparison of concordance rates for glass and digital slide evaluation while minimizing time and effort for the involved personnel. Using a benchmark study design, we demonstrate that evaluation of digital slides fits the purpose of nonclinical safety evaluation. These results add to reports of successful workflow validations and support the full adaptation of digital pathology in the regulatory field.</p>","PeriodicalId":23113,"journal":{"name":"Toxicologic Pathology","volume":" ","pages":"251-257"},"PeriodicalIF":1.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141200582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ginsenoside Rh2 Regulates the Calcium/ROS/CK1α/MLKL Pathway to Promote Premature Eryptosis and Hemolysis in Red Blood Cells. 人参皂苷 Rh2 调节钙/ROS/CK1α/MLKL 通路,促进红细胞过早嗜酸化和溶血
IF 1.4 4区 医学 Q3 PATHOLOGY Pub Date : 2024-07-01 Epub Date: 2024-08-16 DOI: 10.1177/01926233241268846
Sumiah A Alghareeb, Jawaher Alsughayyir, Mohammad A Alfhili

Ginsenoside Rh2 (GRh2) exhibits significant potential as an anticancer agent; however, progress in developing chemotherapeutic drugs is impeded by their toxicity toward off-target tissues. Specifically, anemia caused by chemotherapy is a debilitating side effect and can be caused by red blood cell (RBC) hemolysis and eryptosis. Cells were exposed to GRh2 in the antitumor range and hemolytic and eryptotic markers were examined under different experimental conditions using photometric and cytofluorimetric methods. GRh2 caused Ca2+-independent, concentration-responsive hemolysis in addition to disrupted ion trafficking with K+ and Cl- leakage. Significant increases in cells positive for annexin-V-fluorescein isothiocyanate, Fluo4, and 2,7-dichlorofluorescein were noted upon GRh2 treatment coupled with a decrease in forward scatter and acetylcholinesterase activity. Importantly, the cytotoxic effects of GRh2 were mitigated by ascorbic acid and by blocking casein kinase 1α (CK1α) and mixed lineage kinase domain-like (MLKL) signaling. In contrast, Ca2+ omission, inhibition of KCl efflux, and isosmotic sucrose aggravated GRh2-induced RBC death. In whole blood, GRh2 selectively targeted reticulocytes and lymphocytes. Altogether, this study identified novel mechanisms underlying GRh2-induced RBC death involving Ca2+ buildup, loss of membrane phospholipid asymmetry and cellular volume, anticholinesterase activity, and oxidative stress. These findings shed light on the hematologic toxicity of GRh2 which is crucial for optimizing its utilization in cancer treatment.

人参皂苷 Rh2(GRh2)作为一种抗癌剂具有巨大的潜力;然而,其对非靶组织的毒性阻碍了化疗药物的开发进展。具体来说,化疗引起的贫血是一种使人衰弱的副作用,可由红细胞(RBC)溶血和红细胞增多引起。将细胞暴露于抗肿瘤范围内的 GRh2,在不同的实验条件下使用光度法和细胞荧光法检测溶血和红细胞凋亡标记物。除了K+和Cl-渗漏导致的离子运输紊乱外,GRh2还引起了不依赖于Ca2+的浓度反应性溶血。经 GRh2 处理后,附件素-V-异硫氰酸荧光素、Fluo4 和 2,7-二氯荧光素阳性细胞显著增加,同时前向散射和乙酰胆碱酯酶活性降低。重要的是,抗坏血酸和阻断酪蛋白激酶 1α(CK1α)和混合系激酶域样(MLKL)信号传导可减轻 GRh2 的细胞毒性作用。相反,Ca2+缺失、KCl外流抑制和等渗蔗糖会加剧GRh2-诱导的红细胞死亡。在全血中,GRh2 选择性地靶向网织红细胞和淋巴细胞。总之,本研究发现了 GRh2 诱导 RBC 死亡的新机制,包括 Ca2+ 堆积、膜磷脂不对称和细胞体积损失、抗胆碱酯酶活性和氧化应激。这些发现揭示了 GRh2 的血液学毒性,这对优化其在癌症治疗中的应用至关重要。
{"title":"Ginsenoside Rh2 Regulates the Calcium/ROS/CK1α/MLKL Pathway to Promote Premature Eryptosis and Hemolysis in Red Blood Cells.","authors":"Sumiah A Alghareeb, Jawaher Alsughayyir, Mohammad A Alfhili","doi":"10.1177/01926233241268846","DOIUrl":"10.1177/01926233241268846","url":null,"abstract":"<p><p>Ginsenoside Rh2 (GRh2) exhibits significant potential as an anticancer agent; however, progress in developing chemotherapeutic drugs is impeded by their toxicity toward off-target tissues. Specifically, anemia caused by chemotherapy is a debilitating side effect and can be caused by red blood cell (RBC) hemolysis and eryptosis. Cells were exposed to GRh2 in the antitumor range and hemolytic and eryptotic markers were examined under different experimental conditions using photometric and cytofluorimetric methods. GRh2 caused Ca<sup>2+</sup>-independent, concentration-responsive hemolysis in addition to disrupted ion trafficking with K<sup>+</sup> and Cl<sup>-</sup> leakage. Significant increases in cells positive for annexin-V-fluorescein isothiocyanate, Fluo4, and 2,7-dichlorofluorescein were noted upon GRh2 treatment coupled with a decrease in forward scatter and acetylcholinesterase activity. Importantly, the cytotoxic effects of GRh2 were mitigated by ascorbic acid and by blocking casein kinase 1α (CK1α) and mixed lineage kinase domain-like (MLKL) signaling. In contrast, Ca<sup>2+</sup> omission, inhibition of KCl efflux, and isosmotic sucrose aggravated GRh2-induced RBC death. In whole blood, GRh2 selectively targeted reticulocytes and lymphocytes. Altogether, this study identified novel mechanisms underlying GRh2-induced RBC death involving Ca<sup>2+</sup> buildup, loss of membrane phospholipid asymmetry and cellular volume, anticholinesterase activity, and oxidative stress. These findings shed light on the hematologic toxicity of GRh2 which is crucial for optimizing its utilization in cancer treatment.</p>","PeriodicalId":23113,"journal":{"name":"Toxicologic Pathology","volume":" ","pages":"284-294"},"PeriodicalIF":1.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141988978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biocompatible Solutions: Evaluating the Safety of Repeated Intra-Articular Injections of pMPCylated Liposomes for Knee Osteoarthritis Therapy in Rat Models. 生物相容性解决方案:评估在大鼠模型中重复关节内注射 pMPCylated 脂质体治疗膝骨关节炎的安全性。
IF 1.4 4区 医学 Q3 PATHOLOGY Pub Date : 2024-07-01 Epub Date: 2024-08-28 DOI: 10.1177/01926233241271400
Yuval Ramot, Noam Kronfeld, Michal Steiner, Eric D Lee, Ronit Goldberg, Sabrina Jahn, Abraham Nyska

Knee osteoarthritis (OA) poses a significant health care burden globally, necessitating innovative therapeutic approaches. CCoat, a novel poly(2-[methacryloyloxy]ethyl phosphorylcholine) (pMPC)ylated liposome device, protects the cartilage surface of the joint from mechanical wear through an entropy-favored process. Two preclinical studies were performed to explore the safety of CCoat following repeated intra-articular (IA) injections into the knee joint (i.e., femorotibial joint) in Sprague-Dawley rats. The studies involved 2 or 3 IA injections, at an interval of 2 or 3 weeks, and an observation period of 1 or 13 weeks after the last injection. Assessments included clinical, histopathological, and immunofluorescent evaluations. In study 1, no mortality or abnormal clinical signs occurred. At 1 week post last injection, histopathology revealed minimal vacuolated macrophages beneath the synovial membrane, predominantly M2-like, indicating a nonadverse response. Immunofluorescent staining supported M2-like macrophage predominance. Study 2 confirmed these findings with no systemic effects over 13 weeks. Statistical analyses indicated no significant differences in body weight, clinical pathology, or organ weights compared with controls. Results affirming the safety of pMPCylated liposomes following repeated IA injections in rat. This novel lubricant coating approach shows promise in OA therapy, with this safety assessment supporting its potential clinical application.

膝关节骨关节炎(OA)给全球医疗保健带来了沉重负担,因此需要创新的治疗方法。CCoat是一种新型的聚(2-[甲基丙烯酰氧基]乙基磷酸胆碱)(pMPC)酰化脂质体装置,它能通过一种有利于熵的过程保护关节软骨表面免受机械磨损。我们进行了两项临床前研究,以探索 CCoat 在 Sprague-Dawley 大鼠膝关节(即股胫关节)内反复注射后的安全性。研究涉及 2 或 3 次膝关节内注射,每次间隔 2 或 3 周,最后一次注射后观察 1 或 13 周。评估包括临床、组织病理学和免疫荧光评估。在研究 1 中,没有出现死亡或异常临床症状。最后一次注射后 1 周,组织病理学显示滑膜下有极少量空泡状巨噬细胞,主要为 M2 样,表明无不良反应。免疫荧光染色证实巨噬细胞以 M2 类为主。研究 2 证实了这些结果,13 周内未出现全身性影响。统计分析显示,与对照组相比,体重、临床病理或器官重量均无明显差异。研究结果肯定了在大鼠体内反复注射 pMPCylated 脂质体的安全性。这种新型润滑涂层方法有望用于OA治疗,其安全性评估支持其潜在的临床应用。
{"title":"Biocompatible Solutions: Evaluating the Safety of Repeated Intra-Articular Injections of pMPCylated Liposomes for Knee Osteoarthritis Therapy in Rat Models.","authors":"Yuval Ramot, Noam Kronfeld, Michal Steiner, Eric D Lee, Ronit Goldberg, Sabrina Jahn, Abraham Nyska","doi":"10.1177/01926233241271400","DOIUrl":"10.1177/01926233241271400","url":null,"abstract":"<p><p>Knee osteoarthritis (OA) poses a significant health care burden globally, necessitating innovative therapeutic approaches. CCoat, a novel poly(2-[methacryloyloxy]ethyl phosphorylcholine) (pMPC)ylated liposome device, protects the cartilage surface of the joint from mechanical wear through an entropy-favored process. Two preclinical studies were performed to explore the safety of CCoat following repeated intra-articular (IA) injections into the knee joint (i.e., femorotibial joint) in Sprague-Dawley rats. The studies involved 2 or 3 IA injections, at an interval of 2 or 3 weeks, and an observation period of 1 or 13 weeks after the last injection. Assessments included clinical, histopathological, and immunofluorescent evaluations. In study 1, no mortality or abnormal clinical signs occurred. At 1 week post last injection, histopathology revealed minimal vacuolated macrophages beneath the synovial membrane, predominantly M2-like, indicating a nonadverse response. Immunofluorescent staining supported M2-like macrophage predominance. Study 2 confirmed these findings with no systemic effects over 13 weeks. Statistical analyses indicated no significant differences in body weight, clinical pathology, or organ weights compared with controls. Results affirming the safety of pMPCylated liposomes following repeated IA injections in rat. This novel lubricant coating approach shows promise in OA therapy, with this safety assessment supporting its potential clinical application.</p>","PeriodicalId":23113,"journal":{"name":"Toxicologic Pathology","volume":" ","pages":"266-283"},"PeriodicalIF":1.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11414135/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142081559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characterization of an Uncommon Finding in the Basal Nuclei in Beagle Dogs: A Novel Potential Background Lesion in the Canine Brain. 比格犬基底核不常见发现的特征:犬脑中一种新的潜在背景病变。
IF 1.4 4区 医学 Q3 PATHOLOGY Pub Date : 2024-07-01 Epub Date: 2024-08-16 DOI: 10.1177/01926233241268849
Stefanie Arms, Katja Hempel, Sophie Rau, Julia Schlichtiger, Thomas Nolte

Degenerative lesions specific to the basal nuclei have not been described as a background finding in Beagle dogs. This report comprises a documentation of seven cases. In the context of a nonclinical safety studies, the authors suggest documenting the lesion descriptively as degeneration neuropil, basal nuclei, bilateral as it is characterized by (1) vacuolation, neuropil; (2) gliosis (astro- and/or microgliosis); and (3) demyelination. This novel lesion is considered a potential new background change for several reasons: (1) It occurred in animals from test item-treated and also vehicle-treated groups; (2) no dose dependency was observed; (3) in one of six affected test item-treated dogs, the given compound was shown not to penetrate the blood-brain barrier; and (4) statistical comparison between the proportions of affected dogs in the treatment and control groups did not yield a statistically significant difference. The etiology remains unknown and is subject to further investigations.

在比格犬中,基底核特有的退行性病变尚未被描述为背景发现。本报告记录了 7 个病例。在非临床安全性研究的背景下,作者建议将这种病变描述为双侧基底核神经髓变性,因为它具有以下特征:(1) 空泡化,神经髓;(2) 神经胶质细胞病变(星形胶质细胞和/或微胶质细胞病变);(3) 髓鞘脱失。这种新病变被认为是一种潜在的新背景变化,原因有以下几点:(1) 它发生在试验品处理组和药物处理组的动物身上;(2) 没有观察到剂量依赖性;(3) 在六只受影响的试验品处理犬中,有一只的试验结果表明该化合物不能透过血脑屏障;(4) 对处理组和对照组中受影响犬的比例进行统计比较,没有发现显著的统计学差异。病因仍然不明,有待进一步调查。
{"title":"Characterization of an Uncommon Finding in the Basal Nuclei in Beagle Dogs: A Novel Potential Background Lesion in the Canine Brain.","authors":"Stefanie Arms, Katja Hempel, Sophie Rau, Julia Schlichtiger, Thomas Nolte","doi":"10.1177/01926233241268849","DOIUrl":"10.1177/01926233241268849","url":null,"abstract":"<p><p>Degenerative lesions specific to the basal nuclei have not been described as a background finding in Beagle dogs. This report comprises a documentation of seven cases. In the context of a nonclinical safety studies, the authors suggest documenting the lesion descriptively as <i>degeneration neuropil, basal nuclei, bilateral</i> as it is characterized by (1) vacuolation, neuropil; (2) gliosis (astro- and/or microgliosis); and (3) demyelination. This novel lesion is considered a potential new background change for several reasons: (1) It occurred in animals from test item-treated and also vehicle-treated groups; (2) no dose dependency was observed; (3) in one of six affected test item-treated dogs, the given compound was shown not to penetrate the blood-brain barrier; and (4) statistical comparison between the proportions of affected dogs in the treatment and control groups did not yield a statistically significant difference. The etiology remains unknown and is subject to further investigations.</p>","PeriodicalId":23113,"journal":{"name":"Toxicologic Pathology","volume":" ","pages":"295-301"},"PeriodicalIF":1.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141988977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inter-Rater and Intra-Rater Agreement in Scoring Severity of Rodent Cardiomyopathy and Relation to Artificial Intelligence-Based Scoring. 啮齿动物心肌病严重程度评分中评分者间和评分者内的一致性以及与基于人工智能的评分的关系。
IF 1.4 4区 医学 Q3 PATHOLOGY Pub Date : 2024-07-01 Epub Date: 2024-06-22 DOI: 10.1177/01926233241259998
Thomas J Steinbach, Debra A Tokarz, Caroll A Co, Shawn F Harris, Sandra J McBride, Keith R Shockley, Avinash Lokhande, Gargi Srivastava, Rajesh Ugalmugle, Arshad Kazi, Emily Singletary, Mark F Cesta, Heath C Thomas, Vivian S Chen, Kristen Hobbie, Torrie A Crabbs

We previously developed a computer-assisted image analysis algorithm to detect and quantify the microscopic features of rodent progressive cardiomyopathy (PCM) in rat heart histologic sections and validated the results with a panel of five veterinary toxicologic pathologists using a multinomial logistic model. In this study, we assessed both the inter-rater and intra-rater agreement of the pathologists and compared pathologists' ratings to the artificial intelligence (AI)-predicted scores. Pathologists and the AI algorithm were presented with 500 slides of rodent heart. They quantified the amount of cardiomyopathy in each slide. A total of 200 of these slides were novel to this study, whereas 100 slides were intentionally selected for repetition from the previous study. After a washout period of more than six months, the repeated slides were examined to assess intra-rater agreement among pathologists. We found the intra-rater agreement to be substantial, with weighted Cohen's kappa values ranging from k = 0.64 to 0.80. Intra-rater variability is not a concern for the deterministic AI. The inter-rater agreement across pathologists was moderate (Cohen's kappa k = 0.56). These results demonstrate the utility of AI algorithms as a tool for pathologists to increase sensitivity and specificity for the histopathologic assessment of the heart in toxicology studies.

我们之前开发了一种计算机辅助图像分析算法,用于检测和量化大鼠心脏组织切片中啮齿动物进行性心肌病 (PCM) 的显微特征,并使用多项式逻辑模型与五位兽医毒理学病理学家小组验证了结果。在这项研究中,我们评估了病理学家的评分者之间和评分者内部的一致性,并将病理学家的评分与人工智能(AI)预测的分数进行了比较。我们向病理学家和人工智能算法展示了 500 张啮齿动物心脏的切片。他们对每张切片中心肌病的数量进行量化。其中共有 200 张幻灯片是本研究的新内容,而 100 张幻灯片则是特意从之前的研究中挑选出来的重复内容。经过 6 个多月的缓冲期后,我们对重复的切片进行了检查,以评估病理学家之间的评分内一致性。我们发现评分者内部的一致性非常高,加权科恩卡帕值从 k = 0.64 到 0.80 不等。对于确定性人工智能来说,评分者内部的变异性并不令人担忧。病理学家之间的评分者间一致性为中等(科恩卡帕 k = 0.56)。这些结果证明了人工智能算法作为病理学家提高毒理学研究中心脏组织病理学评估灵敏度和特异性的工具的实用性。
{"title":"Inter-Rater and Intra-Rater Agreement in Scoring Severity of Rodent Cardiomyopathy and Relation to Artificial Intelligence-Based Scoring.","authors":"Thomas J Steinbach, Debra A Tokarz, Caroll A Co, Shawn F Harris, Sandra J McBride, Keith R Shockley, Avinash Lokhande, Gargi Srivastava, Rajesh Ugalmugle, Arshad Kazi, Emily Singletary, Mark F Cesta, Heath C Thomas, Vivian S Chen, Kristen Hobbie, Torrie A Crabbs","doi":"10.1177/01926233241259998","DOIUrl":"10.1177/01926233241259998","url":null,"abstract":"<p><p>We previously developed a computer-assisted image analysis algorithm to detect and quantify the microscopic features of rodent progressive cardiomyopathy (PCM) in rat heart histologic sections and validated the results with a panel of five veterinary toxicologic pathologists using a multinomial logistic model. In this study, we assessed both the inter-rater and intra-rater agreement of the pathologists and compared pathologists' ratings to the artificial intelligence (AI)-predicted scores. Pathologists and the AI algorithm were presented with 500 slides of rodent heart. They quantified the amount of cardiomyopathy in each slide. A total of 200 of these slides were novel to this study, whereas 100 slides were intentionally selected for repetition from the previous study. After a washout period of more than six months, the repeated slides were examined to assess intra-rater agreement among pathologists. We found the intra-rater agreement to be substantial, with weighted Cohen's kappa values ranging from k = 0.64 to 0.80. Intra-rater variability is not a concern for the deterministic AI. The inter-rater agreement across pathologists was moderate (Cohen's kappa k = 0.56). These results demonstrate the utility of AI algorithms as a tool for pathologists to increase sensitivity and specificity for the histopathologic assessment of the heart in toxicology studies.</p>","PeriodicalId":23113,"journal":{"name":"Toxicologic Pathology","volume":" ","pages":"258-265"},"PeriodicalIF":1.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11412787/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141440918","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Toxicologic Pathology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1